FIELD: medicine, pharmaceutics.
SUBSTANCE: the present innovation deals with pharmaceutical preparations for treating wounds and/or infections of human or animal internal organs being sensitive to injection of such agents. The preparation suggested is being a liposome including, at least, one antiphlogistic agent chosen out of antiseptics group that represent compounds producing oxygen or halogen, metal compounds, such as compounds of silver or mercury, organic disinfecting substances including compounds producing formaldehyde, alcohols, phenols, including alkyl- and arylphenols, and, also, halogenated phecols, quinolines and acridines, hexahydropyrimidine, quaternary ammonium compounds and iminic salts and guanidines, or its combination with, at least, one agent that stimulates wound healing chosen out of agents stimulating granulation and epithelization, such as dexpanthenol, allantoins, azulenes, tannins, compounds of vitamin B row or agents of similar action. The innovation enables to obtain highly tolerant, easily introduced preparation that provides prolonged removal and prolonged local effect of the action of active agent inside the body due to interaction with cell surface.
EFFECT: higher efficiency.
12 cl, 3 ex, 1 tbl
